Search Results - "Dietrich, Eric A."
-
1
Comparative effectiveness and safety of direct oral anticoagulants versus warfarin among patients with recurrent venous thromboembolism
Published in Clinical and translational science (01-06-2023)“…The comparative effectiveness and safety of oral anticoagulant therapies to prevent a second recurrent venous thromboembolism (VTE) remains undetermined. We…”
Get full text
Journal Article -
2
Trends in pharmacotherapy utilization among patients with heart failure with preserved ejection fraction
Published in American heart journal plus (01-02-2023)“…Half of patients with heart failure have preserved ejection fraction (HFpEF). Over the years, guidelines have recommended or advised against various therapies…”
Get full text
Journal Article -
3
Comparative effectiveness and safety of extended anticoagulant therapy among Medicare beneficiaries with venous thromboembolism
Published in Clinical and translational science (01-01-2023)“…Guidelines recommend an extended course of anticoagulation therapy for patients who experienced venous thromboembolism (VTE) without transient provocation,…”
Get full text
Journal Article -
4
Semaglutide for Weight Loss
Published in The Annals of pharmacotherapy (01-02-2022)Get full text
Journal Article -
5
Out-of-Pocket Payment for Ambulatory Blood Pressure Monitoring Among Commercially Insured in the United States
Published in American journal of hypertension (03-11-2020)“…Abstract Background Clinical guidelines increasingly recommended ambulatory blood pressure monitoring (ABPM) for hypertension diagnosis and management. Yet,…”
Get full text
Journal Article -
6
Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors among patients with heart failure with preserved ejection fraction
Published in Pharmacotherapy (01-10-2023)“…Sodium-glucose cotransporter-2 inhibitors (SGLT2i) are recommended by the American Heart Association for management of heart failure with preserved ejection…”
Get full text
Journal Article -
7
Comparative effectiveness of sacubitril/valsartan versus angiotensin receptor blockers in patients with heart failure with preserved ejection fraction: A real-world study
Published in American journal of health-system pharmacy (08-07-2024)“…In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been…”
Get full text
Journal Article -
8
Trajectories of Oral Anticoagulation Adherence and Associated Clinical Outcomes During Long-Term Anticoagulation Among Medicare Beneficiaries With Venous Thromboembolism
Published in The Annals of pharmacotherapy (01-12-2023)“…Background: Little is known about anticoagulation medication nonadherence patterns impacting effectiveness and safety outcomes in clinical practice. Objective:…”
Get full text
Journal Article -
9
Comparative Genitourinary Safety of In-class Sodium-Glucose Cotransporter-2 Inhibitors among Patients with Heart Failure with Preserved Ejection Fraction: A Cohort Study
Published in American journal of cardiovascular drugs : drugs, devices, and other interventions (01-05-2024)“…Purpose The American Heart Association recommended sodium-glucose cotransporter-2 inhibitors (SGLT2i) for the management of heart failure with preserved…”
Get full text
Journal Article -
10
Effectiveness of sacubitril/valsartan versus aldosterone antagonists in heart failure with reduced ejection fraction: A retrospective cohort study
Published in Pharmacotherapy (01-09-2021)“…Study Objective To assess the effectiveness of sacubitril/valsartan versus angiotensin receptor antagonist therapy for prevention of heart failure (HF)‐related…”
Get full text
Journal Article -
11
Effectiveness and Safety of Extended Oral Anticoagulant Therapy in Patients with Venous Thromboembolism: A Retrospective Cohort Study
Published in Clinical pharmacology and therapeutics (01-07-2022)“…Limited real‐world evidence exists for effectiveness and safety of extended oral anticoagulation beyond 6 months of initial treatment in prevention of…”
Get full text
Journal Article -
12
Comparison of effectiveness and safety for low versus full dose of apixaban during extended phase oral anticoagulation in patients with venous thromboembolism
Published in Journal of internal medicine (01-06-2022)“…Background The optimal dose of apixaban therapy to prevent asecondary venous thromboembolism (VTE) event remains unconfirmed. To investigate the effects of…”
Get full text
Journal Article -
13
Trajectories of adherence to extended treatment with direct oral anticoagulants and risks of recurrent venous thromboembolism and major bleeding
Published in Journal of managed care & specialty pharmacy (01-11-2023)“…Little is known about medication adherence patterns and their association with effectiveness and safety among patients with venous thromboembolism (VTE)…”
Get full text
Journal Article -
14
Trends in ambulatory blood pressure monitoring use for confirmation or monitoring of hypertension and resistant hypertension among the commercially insured in the U.S., 2008–2017
Published in International Journal of Cardiology Hypertension (Online) (01-09-2020)“…Ambulatory blood pressure monitoring (ABPM) has been increasingly recommended for diagnosis confirmation and monitoring in patients with new-onset hypertension…”
Get full text
Journal Article -
15
The use of apixaban as a perioperative bridge for warfarin in a patient unable to use parenteral anticoagulation: A case report
Published in Thrombosis update (01-08-2021)“…Patients receiving chronic warfarin therapy for secondary venous thromboembolism (VTE) prevention often require therapeutic interruptions surrounding planned…”
Get full text
Journal Article -
16
Evaluation of SAMe-TT2R2 Score on Predicting Success With Extended-Interval Warfarin Monitoring
Published in The Annals of pharmacotherapy (01-11-2018)“…Background: In patients with stable international normalized ratios, 12-week extended-interval warfarin monitoring can be considered; however, predictors of…”
Get full text
Journal Article -
17
Evaluation of SAMe-TT 2 R 2 Score on Predicting Success With Extended-Interval Warfarin Monitoring
Published in The Annals of pharmacotherapy (01-11-2018)“…In patients with stable international normalized ratios, 12-week extended-interval warfarin monitoring can be considered; however, predictors of success with…”
Get full text
Journal Article -
18
Design and Early Implementation Successes and Challenges of a Pharmacogenetics Consult Clinic
Published in Journal of clinical medicine (17-07-2020)“…Pharmacogenetic testing (PGT) is increasingly being used as a tool to guide clinical decisions. This article describes the development of an outpatient,…”
Get full text
Journal Article -
19
Trajectories of adherence to extended treatment with warfarin and risks of recurrent venous thromboembolism and major bleeding
Published in Research and practice in thrombosis and haemostasis (01-03-2023)“…Little is published about warfarin therapy adherence patterns beyond 6 months of initial anticoagulant treatment and their association with effectiveness and…”
Get full text
Journal Article -
20
Patient satisfaction with extended-interval warfarin monitoring
Published in Journal of thrombosis and thrombolysis (01-11-2016)“…Extended-interval monitoring of warfarin has been proposed to reduce follow-up burden and improve patient satisfaction. We aimed to make an initial assessment…”
Get full text
Journal Article